Non-valvular atrial fibrillation accounts for 13–26% of acute ischaemic strokes.1 Direct oral anticoagulants (DOACs) are ...

Patients with atrial fibrillation who have experienced a stroke would benefit greatly from earlier treatment than is ...

The CATALYST meta-analysis pooled the four studies and identified 5,441 people with acute ischemic stroke and Afib for ...

Atrial fibrillation (AF) is a prevalent cardiac arrhythmia that significantly elevates the risk of thromboembolic events, most notably ischaemic stroke. Anticoagulation therapy has long been a ...

Patients with atrial fibrillation who have experienced a stroke would benefit greatly from earlier treatment than is ...

Cite this: Use of Anticoagulation in Elderly Patients with Atrial Fibrillation Who Are at Risk for Falls - Medscape - Apr 01, 2008.

Patients with atrial fibrillation who have experienced a stroke would benefit greatly from earlier treatment than is ...

Clinical experience with these new anticoagulation agents in association with an AF ablation procedure at the present time is limited. [10–15, 21] In a case-control comparison, Lakkireddy et al ...

Investigators studied apixaban pharmacokinetics, pharmacodynamics, and hemorrhage risk by kidney function. Kidney function is a major predictor of hemorrhage among patients with atrial fibrillation ...

A true test of durability will take many more years, but if the valve holds up, it’s “potentially a game changer,” say ...

THE most common sustained heart irregularity is atrial fibrillation (A-Fib), where the atria (upper chambers of the heart} ...

There is increased risk for pulmonary hypertension in patients with both atrial fibrillation and incident venous thromboembolism.